# Shanghai MicroPort Medical (Group) Co. trials: 22 (2026)

ClinicalTrials.gov lists 22 trials with Shanghai MicroPort Medical (Group) Co., Ltd. as lead sponsor, 0 of them recruiting or not yet recruiting.

## The full list

Clinical trials led by Shanghai MicroPort Medical (Group) Co., Ltd.: 22 rows for $5, every trial on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/shanghai-microport-medical-group-co-ltd

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 27, 2023 | NCT05961787 | A Trial of DCB vs DES in the Treatment of de Novo Large Diameter Coronary Atherosclerotic Stenosis(LARGE ONE) | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Unknown | Coronary Artery Disease | 134 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05961787) |
| July 6, 2021 | NCT04951050 | TARGET-PREMIER Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in CAS Treatment | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Active not recruiting | Coronary Artery Disease, Coronary Stenosis | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04951050) |
| June 9, 2021 | NCT04918615 | Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated Lesions | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Unknown | Coronary Artery Disease | 236 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04918615) |
| September 24, 2020 | NCT04562532 | Firehawk Rapamycin Target Eluting Coronary Stent North American Trial | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Active not recruiting | Coronary Artery Disease | 1,720 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04562532) |
| September 3, 2020 | NCT04538001 | Safety and Efficacy of Rotator Cuff Function Restoration Balloon in Irreparable Rotator Cuff Tear | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Unknown | Rotator Cuff Tears | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04538001) |
| July 21, 2020 | NCT04479722 | Using Left Atrium Appendage Closure in NVAF Patients With High Risk of Ischemic Stroke | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Unknown | Atrial Fibrillation, Stroke | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04479722) |
| May 13, 2020 | NCT04386213 | Trial for MicroPort's DCB | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Unknown | Coronary Artery In-stent Restenosis | 216 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04386213) |
| September 6, 2018 | NCT03660202 | Trial for MicroPort's Firesorb BVS: FUTURE-III | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Unknown | Coronary Artery Disease | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03660202) |
| July 2, 2018 | NCT03574636 | OCT vs IVUS vs QCA to Guide Moderate-to-severe Calcified Lesion Stent Implantation | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Unknown | Optical Coherence Tomography, Intravascular Ultrasound, Angiography | 375 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03574636) |
| September 19, 2017 | NCT03287167 | Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary... | Shanghai MicroPort Medical (Group) Co., Ltd. | Phase 4 | Unknown | Coronary Disease, Drug Eluting Stent, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy | 1,720 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03287167) |
| February 2, 2017 | NCT03040934 | Firehawk™ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s) | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Unknown | Drug-Eluting Stents, Percutaneous Coronary Intervention, Tomography, Optical Coherence | 196 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03040934) |
| January 2, 2017 | NCT03008083 | Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation | Shanghai MicroPort Medical (Group) Co., Ltd. | Phase 4 | Unknown | Drug-Eluting Stents, Percutaneous Coronary Intervention | 2,446 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03008083) |
| September 7, 2016 | NCT02890160 | A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Completed | Coronary Artery Disease | 430 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02890160) |
| February 23, 2016 | NCT02688868 | Evaluation of New Specifications (2.25mm) of FirehawkTM in the Treatment of Coronary Heart Disease ( Firehawk\_2.25 ) | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Completed | Coronary Heart Disease | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02688868) |
| February 23, 2016 | NCT02688842 | Evaluation of New Specifications (38mm) of FirehawkTM in the Treatment of Coronary Heart Disease | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Completed | Coronary Heart Disease | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02688842) |
| February 23, 2016 | NCT02688829 | The First-In-Man Pilot Study of Firehawk | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Completed | Coronary Heart Disease | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02688829) |
| January 20, 2016 | NCT02659254 | A First-in-Man Study of the Firesorb BVS (FUTURE-I) | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Completed | Coronary Artery Disease | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02659254) |
| August 11, 2015 | NCT02520180 | Non-inferiority Study Comparing Firehawk Stent With Abbott Xience Family Stent (TARGET-AC) | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Completed | Coronary Artery Disease | 1,653 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02520180) |
| August 21, 2014 | NCT02221921 | Safety and Efficacy Study of MicroPort's Transcatheter Aortic Valve and Delivery System for TAVI | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Unknown | Aortic Valve Disease, Aortic Valve Stenosis, Aortic Valve Calcification | 89 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02221921) |
| August 9, 2011 | NCT01412164 | Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD) | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Completed | Coronary Artery Disease | 730 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01412164) |
| September 8, 2010 | NCT01196819 | Randomized MicroPort's Firehawk DES Versus Xience V: TARGET I Trial | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Completed | Coronary Artery Disease | 458 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01196819) |
| March 25, 2009 | NCT00868829 | Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial | Shanghai MicroPort Medical (Group) Co., Ltd. | Not applicable | Unknown | Coronary Heart Disease | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00868829) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 4 | 2 |
| Not applicable | 20 |

## By status

| Status | Trials |
| --- | --- |
| Unknown | 12 |
| Completed | 8 |
| Active not recruiting | 2 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Coronary Artery Disease | 10 |
| Coronary Disease | 5 |
| Aortic Valve Disease | 1 |
| Aortic Valve Stenosis | 1 |
| Aortic Valve, Calcification of | 1 |
| Coronary Stenosis | 1 |
| Atrial Fibrillation | 1 |
| Stroke | 1 |
| Ischemic Stroke | 1 |
| Rotator Cuff Injuries | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Building supply stores in the United States](https://specstream.ai/data/businesses/building-supply-stores/united-states)
- [Packing services in the United States](https://specstream.ai/data/businesses/packing-services/united-states)
- [Caribbean restaurants in the United States](https://specstream.ai/data/businesses/caribbean-restaurants/united-states)
- [Pediatric orthopedic surgery practices in the United States](https://specstream.ai/data/businesses/pediatric-orthopedic-surgery-practices/united-states)
- [Civil rights law firms in the United States](https://specstream.ai/data/businesses/civil-rights-law-firms/united-states)
- [Poke restaurants in the United States](https://specstream.ai/data/businesses/poke-restaurants/united-states)
